First Time Loading...

Taro Pharmaceutical Industries Ltd
NYSE:TARO

Watchlist Manager
Taro Pharmaceutical Industries Ltd Logo
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Watchlist
Price: 42.3 USD -0.26%
Updated: May 13, 2024

Taro Pharmaceutical Industries Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Taro Pharmaceutical Industries Ltd
Research & Development Peer Comparison

Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Research & Development
-$60.3m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
-1%
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Research & Development
-$953m
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
4%
I
InterCure Ltd
TASE:INCR
Research & Development
-₪550k
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
-14%
Mediwound Ltd
NASDAQ:MDWD
Research & Development
-$7.1m
CAGR 3-Years
1%
CAGR 5-Years
17%
CAGR 10-Years
-7%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Research & Development
-₪3.7m
CAGR 3-Years
-30%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
C
Cannassure Therapeutics Ltd
TASE:CSURE
Research & Development
-₪2.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Taro Pharmaceutical Industries Ltd's Research & Development?
Research & Development
-60.3m USD

Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Research & Development amounts to -60.3m USD.

What is Taro Pharmaceutical Industries Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-1%

Over the last year, the Research & Development growth was -19%.